Prevalence of possible drug-drug interactions between ritonavir and other antiretroviral drugs in a private health care sector in South Africa
- At: 2008 FIP Congress in Basel (Switzerland)
- Type: Poster
- By: TRUTER, Ilse (Drug Utilization Research Unit, Nelson Mandela Metropolitan University, Port Elizabeth, South Africa)
- Co-author(s): Katende-Kyenda, Norah (Department of Pharmacology, Walter Sisulu University, Mthatha, South Africa)
Lubbe, Martie (Pharmacy Practice, North-West University, Potchefstroom, South Africa)
Serfontein, Jan (Pharmacy Practice, North-West University, Potchefstroom, South Africa)
Background: The introduction of human immunodeficiency virus (HIV) protease inhibitors (PIs) has led to a dramatic decline in the morbidity and mortality associated with HIV infection, though concomitant use of PIs and other antiretrovirals (ARVs) can be complicated by drug-drug interactions (DDIs), adversely affecting levels of PIs...
Primary aim: The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.